A review on leukotrienes and their receptors with reference to asthma

References

• Back M. Functional characteristics of cysteinyl-leukotriene receptor subtypes. Life Sci 2002;71:611–622
   PubMed Web of Science ®Google Scholar
• Boyce J. Eicosanoids in asthma, allergic inflammation, and host defense. Curr Mol Med 2008;8:335–339
   PubMed Web of Science ®Google Scholar
• Broide D. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007. J Allergy Clin Immunol 2008;122:475–480
   PubMed Web of Science ®Google Scholar
• Capra V. Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol Res 2004;50:1–11
   PubMed Web of Science ®Google Scholar
• Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE. Cysteinyl-leukotrienes and their receptors in asthma and other infammatory diseases: critical update and emerging trends. Med Res Rev 2007;27:469–527
   PubMed Web of Science ®Google Scholar
• Dahlen S. Treatment of asthma with antileukotrienes: first line or last resort therapy? Eur J Pharmacol 2006;533:40–56
   PubMed Web of Science ®Google Scholar
• Montuschi P, Sala A, Dahlen SE, Folco G. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Discov Today 2007;12:404–412
   PubMed Web of Science ®Google Scholar
• Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568–575
   PubMed Web of Science ®Google Scholar
• Samuelsson B. The discovery of the leukotrienes. Am J Respir Crit Care Med 2000;161:S2–S6
   PubMed Web of Science ®Google Scholar
• Bisgaard H. Role of leukotrienes in asthma pathophysiology. Pediatr Pulmonol 2000;30:166–176
   PubMed Web of Science ®Google Scholar
• Di Gennaro A, Haeggstrom J. The leukotrienes: immune modulating lipid mediators of disease. Adv Immunol 2012;116:51–92
   PubMed Web of Science ®Google Scholar
• Drazen J, Austen K. Leukotrienes and airway responses. Am Rev Respir Dis 1987;135:333–337
   PubMedGoogle Scholar
• Jawien J, Korbut R. The current view on the role of leukotrienes in atherogenesis. J Physiol Pharmacol 2010;61:647–650
   PubMed Web of Science ®Google Scholar
• Nicosia S, Capra V, Rovati G. Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 2001;14:3–19
   PubMed Web of Science ®Google Scholar
• Funk C. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871–1875
   PubMed Web of Science ®Google Scholar
• Miller DK, Gillard JW, Vickers PJ, Sadowski S, Léveillé C, Mancini JA, Charleson P, et al. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 1990;343:278–281
   PubMed Web of Science ®Google Scholar
• Rinaldo-Matthis A, Haeggstrom JZ. Structures and mechanisms of enzymes in the leukotriene cascade. Biochimie 2010;92:676–681
   PubMed Web of Science ®Google Scholar
• Lam B, Penrose J, Freeman G, Austen K. Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci USA 1994;91:7663–7667
   PubMed Web of Science ®Google Scholar
• Lewis R, Robin J. Arachidonic acid derivatives as mediators of asthma. J Allergy Clin Immunol 1985;76:259–264
   PubMed Web of Science ®Google Scholar
• Orning L, Hammmarstrom S. Inhibition of leukotriene C4 and D4 biosynthesis. J Biol Chem 1980;255:8023–8026
   PubMed Web of Science ®Google Scholar
• Lee TH, Woszczek G, Farooque SP. Leukotriene E4: perspective on the forgotten mediator. J Allergy Clin Immunol 2009;124:417–421
   PubMed Web of Science ®Google Scholar
• Dahinden C, Clancy R, Gross M, Chiller J, Hugli T. Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. Proc Natl Acad Sci USA 1985;82:6632–6636
   PubMed Web of Science ®Google Scholar
• Bigby T, Lee D, Meslier N, Gruenert D. Leukotriene A4 hydrolase activity of human airway epithelial cells. Biochem Biophys Res Commun 1989;164:1–7
   PubMed Web of Science ®Google Scholar
• Brady H, Serhan C. Adhesion promotes transcellular leukotriene biosynthesis during neutrophil glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin. Biochem Biophys Res Commun 1992;186:1307–1314
   PubMed Web of Science ®Google Scholar
• Amat M, Diaz C, Vila L. Leukotriene A4 hydrolase and leukotriene C4 synthase activities in human chondrocytes: transcellular biosynthesis of Leukotrienes during granulocyte-chondrocyte interaction. Arthritis Rheum 1998;41:1645–1651
   PubMedGoogle Scholar
• Iversen L, Kristensen P, Gron B, Ziboh V, Kragballe K. Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism. Arch Dermatol Res 1994;286:261–266
   PubMed Web of Science ®Google Scholar
• Pergola C, Dodt G, Rossi A, Neunhoeffer E, Lawrenz B, Northoff H, Samuelsson B, et al. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci USA 2008;105:19881–19886
   PubMed Web of Science ®Google Scholar
• Im D. New intracellular lipid mediators and their GPCRs: an update. Prostaglandins Other Lipid Mediat 2009;89:53–56
   PubMed Web of Science ®Google Scholar
• O'Byrne PM, Gauvreau GM, Murphy DM. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma. J Allergy Clin Immunol 2009;124:397–403
   PubMed Web of Science ®Google Scholar
• Rovati GE, Capra V. Cysteinyl-leukotriene receptors and cellular signals. The Scientific World Journal 2007;7 (Special issue: Eicosanoid receptors and inflammation):1375–1392
   Google Scholar
• Back M, Dahlen S, Drazen J, Evans J, Serhan C, Shimizu T, Yokomizo T, et al. International Union of basic and clinical pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution and pathophysiological function. Pharmacol Rev 2011;63:539–584
   PubMed Web of Science ®Google Scholar
• Chebolu S, Wang Y, Ray AP, Darmani NA. Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva). Eur J Pharmacol 2010;628:195–201
   PubMed Web of Science ®Google Scholar
• Labat C, Ortiz J, Norel X, Gorenne I, Verley J, Abram T, Cuthbert NJ, et al. A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther 1992;263:800–805
   PubMed Web of Science ®Google Scholar
• Laidlaw T, Boyce J. Cysteinyl leukotriene receptors, old and new; implications for asthma. Clin Exp Allergy 2012;42:1313–1320
   PubMed Web of Science ®Google Scholar
• Laidlaw T, Kidder M, Bhattacharyya N, Xing W, Shen S, Milne GL, Castells MC, et al. Cysteinyl leukotriene over production in aspirin exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012;119:3790–3798
   PubMed Web of Science ®Google Scholar
• Tudhope S, Cuthbert N, Abram T, Jennings M, Maxey R, Thompson A, Norman P, et al. BAY u9773, a novel antagonist of cysteinyl leukotrienes with activity against two receptor subtypes. Eur J Pharmacol 1994;264:317–323
   PubMed Web of Science ®Google Scholar
• Wunder F, Tinel H, Kast R, Geerts A, Becker E, Kolkhof P, Hütter J, et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor. Br J Pharmacol 2010;160:399–409
   PubMed Web of Science ®Google Scholar
• Yan D, Stocco R, Sawyer N, Nesheim M, Abramovitz M, Funk C. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT2) Agonist, N -MethylLeukotriene C4, in calcium reporter and arrestin assays. Mol Pharmacol 2011;79:270–278
   PubMed Web of Science ®Google Scholar
• Evans JF. The cysteinyl leukotriene receptors. Prostaglandins Leukot Essent Fatty Acids 2003;69:117–122
   PubMed Web of Science ®Google Scholar
• Heise C, O’Dowd B, Figueroa D, Sawyer N, Nguyen T, Im D-S, Stocco R, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000;275:30531–30536
   PubMed Web of Science ®Google Scholar
• Lynch K, Gary P, O’neill G, Qingyun Liu Q, Im D-S, Sawyer N, Coulombe N, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789–793
   PubMed Web of Science ®Google Scholar
• Martin V, Sawyer N, Stocco R, Unett D, Lerner MR, Abramovitz M, Funk CD. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT1) receptors. Biochem Pharmacol 2001;62:1193–1200
   PubMed Web of Science ®Google Scholar
• Sarau H, Ames R, Chambers J, Ellis C, Elshourbagy N, Foley J, Schmidt DB, et al. Identification, molecular cloning, expression and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999;56:657–663
   PubMed Web of Science ®Google Scholar
• Takasaki J, Kamohara M, Matsumoto M, Saito T, Sugimoto T, Ohishi T, Ishii H, et al. The Molecular Characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor. Biochem Biophy Res Commun 2000;274:316–322
   PubMed Web of Science ®Google Scholar
• Evans JF. Cysteinyl leukotriene receptors. Prostaglandins Other Lipid Mediat 2002;68–69:587–597
   PubMed Web of Science ®Google Scholar
• Hui Y, Funk CD. Cysteinyl leukotriene receptors. Biochem Pharmacol 2002;64:1549–1557
   PubMed Web of Science ®Google Scholar
• Rovati GE, Capra V, Nicosia S. More on the classification of cysteinyl leukotriene receptors: subclassification of CysLT1 and CysLT2 receptors based on endogenous ligands. Trends Pharmacol Sci 1997;18:148–149
   PubMed Web of Science ®Google Scholar
• Zhu J, Qiu Y, Figueroa D, Bandi V, Galczenski H, Hamada K, Guntupalli KK, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 2005;33:531–540
   PubMed Web of Science ®Google Scholar
• Nothacker H, Wang Z, Zhu Y, Reinscheid R, Lin S, Civelli O. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 2000;58:1601–1608
   PubMed Web of Science ®Google Scholar
• Feuerstein G. Leukotrienes and the cardiovascular system. Prostaglandins 1984;27:781–802
   PubMed Web of Science ®Google Scholar
• Bizzintino JA, Khoo S-K, Zhang G, Martin AC, Rueter K, Geelhoed GC, Goldblatt J, et al. Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma. Prostaglandins Leukot Essent Fatty Acids 2009;81:9–15
   PubMed Web of Science ®Google Scholar
• Okunishi K, Peters-Golden M. Leukotrienes and airway inflammation. Biochimica et Biophysica Acta 2011;1810:1096–1102
   PubMed Web of Science ®Google Scholar
• Samuelsson B, Dahlen S, Lindgren J, Rouzer C, Serhan C. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987;237:1171–1176
   PubMed Web of Science ®Google Scholar
• Austen KF, Maekawa A, Kanaoka Y, Boyce JA. The leukotriene E4 puzzle: Finding the missing pieces and revealing the pathobiologic implications. J Allergy Clin Immunol 2009;124:406–414
   PubMed Web of Science ®Google Scholar
• Coleman R, Eglen R, Jones R, Narumiya S, Shimizu T, Smith W, Dahlén SE, et al. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv Prostaglandin Thromboxane Leukot Res 1995;23:283–285
   PubMedGoogle Scholar
• Mellor E, Maekawa A, Austen K, Boyce J. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA 2001;98:7964–7969
   PubMed Web of Science ®Google Scholar
• Paruchuri S, Tashimo H, Feng C, Maekawa A, Xing W, Jiang Y, Kanaoka Y, et al. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 2009;206:2543–2555
   PubMed Web of Science ®Google Scholar
• Back M, Norel X, Walch L, Gascard J, Brink C. A new functional cysteinyl leukotriene receptor in the pulmonary artery. Mediators Inflamm 1999;8:S48--S53
   Google Scholar
• Back M, Norel X, Walch L, Gascard J, de Montpreville V, Dahlen S, Brink C. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes. Eur J Pharmacol 2000;401:389–395
   PubMed Web of Science ®Google Scholar
• Allen S, Dashwood M, Morrison K, Yacoub M. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. Circulation 1998;97:2406–2413
   PubMed Web of Science ®Google Scholar
• Ravasi S, Capra V, Mezzetti M, Nicosia S, Rovati G. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C4 binding site not coupled to contraction in human lung parenchyma. Mol Pharmacol 2000;57:1182–1189
   PubMed Web of Science ®Google Scholar
• Ravasi S, Capra V, Panigalli T, Rovati G, Nicosia S. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma. Biochem Pharmacol 2002;63:1537–1546
   PubMed Web of Science ®Google Scholar
• Walch L, Norel X, Back M, Gascard J, Dahlen S, Brink C. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle. Br J Pharmacol 2002;137:1339–1345
   PubMed Web of Science ®Google Scholar
• Maekawa A, Kanaoka Y, Xing W, Austen K. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc Natl Acad Sci USA 2008;105:16695–16700
   PubMed Web of Science ®Google Scholar
• Kanaoka Y, Maekawa A, Austen KF. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. J Biol Chem 2013;288:10967–10972
   PubMed Web of Science ®Google Scholar
• Capra V, Ravasi S, Accomazzo M, Citro S, Grimoldi M, Abbracchio MP, Rovati GE. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation. J Cell Sci 2005;118:5625–5636
   PubMed Web of Science ®Google Scholar
• Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 2006;25:4615–4627
   PubMed Web of Science ®Google Scholar
• Ceruti S, Villa G, Genovese T, Mazzon E, Longhi R, Rosa P, Bramanti P, et al. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain 2009;132:2206–2218
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Redhu NS, Ojo OO, Liu B, Irechukwu N, Billington C, Janssen L, Moir LM. Emerging airway smooth muscle targets to treat asthma. Pulm Pharmacol Ther. 2013;26:132–144
   PubMed Web of Science ®Google Scholar
• Krouse JH, Brown RW, Fineman SM, Han JK, Heller AJ, Joe S, Krouse HJ, et al. Asthma and the unified airway. Otolaryngol Head Neck Surg 2007;136:S75–S106
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock I. Pharmacology of airway inflammation in asthma and COPD. Pulm Pharmacol Ther 2003;16:247–277
   PubMed Web of Science ®Google Scholar
• Dahlén SE. Treatment of asthma with antileukotrienes: first line or last resort therapy? Eur J Pharmacol 2006;533:40–56
   PubMed Web of Science ®Google Scholar
• Jarjour N, Kelly E. Pathogenesis of asthma. Med Clin North Am 2002;86:925–936
   PubMed Web of Science ®Google Scholar
• Ellis J, Undem B. Role of cysteinyl leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi. Am J Respir Crit Care Med 1994;149:118–122
   PubMed Web of Science ®Google Scholar
• Watson N, Magnussen H, Rabe K. Inherent tone of human bronchus: role of eicosanoids and the epithelium. Br J Pharmacol 1997;121:1099–1104
   PubMed Web of Science ®Google Scholar
• Wenzel SE. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids 2003;69:145–155
   PubMed Web of Science ®Google Scholar
• Arm J. Leukotriene generation and clinical implications. Allergy Asthma Proc 2004;25:37–42
   PubMed Web of Science ®Google Scholar
• Hallstrand TS, Henderson Jr WR. The evolving role of intravenous leukotriene modifiers in acute asthma. J Allergy Clin Immunol 2010;125:381–382
   PubMed Web of Science ®Google Scholar
• Lam S, Chan H, LeRiche J, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711–717
   PubMed Web of Science ®Google Scholar
• Mita H, Hasegawa M, Saito H, Akiyama K. Levels of cysteinyl leukotriene receptor mRNA in human peripheral leukocytes: significantly higher expression of cysteinyl receptor2 mRNA in eosinophils. Clin Exp Allergy 2001;31:1714–1723
   PubMed Web of Science ®Google Scholar
• Sampson A, Siddiqui S, Buchanan D, Howarth P, Holgate S, Holloway J, Sayers I. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000;55:S28–S31
   PubMed Web of Science ®Google Scholar
• Sousa A, Parikh A, Scadding G, Corrigan C, Lee T. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493–1499
   PubMed Web of Science ®Google Scholar
• Dahlen S, Hansson G, Hedqvist P, Bjorck T, Granstrom E, Dahlen B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4 and E4. Proc Natl Acad Sci USA 1983;80:1712–1716
   PubMed Web of Science ®Google Scholar
• Back M, Kumlin M, Cotgreave I, Dahlen S. An alternative pathway for metabolism of leukotriene D4: effects on contractions to cysteinyl-leukotrienes in the guinea pig trachea. Br J Pharmacol 2001;133:1134–1144
   PubMed Web of Science ®Google Scholar
• Baker S, Boot J, Jamieson W, Osborne D, Sweatman W. The comparative in vitro pharmacology of leukotriene D4 and its isomers. Biochem Biophys Res Commun 1981;103:1258–1264
   PubMed Web of Science ®Google Scholar
• Muraki M, Imbe S, Santo H, Sato R, Sano H, Iwanaga T, Tohda Y. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Int Arch Allergy Appl Immunol 2011;155:90–95
   Google Scholar
• Lee TH, Austen KF, Corey EJ, Drazen JM. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci USA 1984;81:4922–4925
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Calhoun WJ. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 2006;118:789–798
   PubMed Web of Science ®Google Scholar
• Neves JS, Radke AL, Weller PF. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. J Allergy Clin Immunol 2010;125:477–482
   PubMed Web of Science ®Google Scholar
• Arm J, O’Hickey S, Spur B, Lee T. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 1989;140:148–153
   PubMed Web of Science ®Google Scholar
• Hand J, Schwalm S. Pharmacological comparison of L-serine borate and glutathione as inhibitors of metabolism of LTC4 to LTD4 by the isolated guinea pig trachea. Prostaglandins 1987;33:709–716
   PubMed Web of Science ®Google Scholar
• Hand J, Schwalm S, Englebach I, Auen M, Musser J, Kreft A. Pharmacological characterization using selected antagonists of the leukotriene receptors mediating contraction of guinea-pig trachea. Prostaglandins 1989;37:181–191
   PubMedGoogle Scholar
• Harrison S, Gatti R, Baraldo S, Oliani KL, Andre E, Trevisani M, Gazzieri D, et al. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig. Pulm Pharm Ther 2008;21:317–323
   PubMed Web of Science ®Google Scholar
• Riccioni G, Back M, Capra V. Leukotrienes and atherosclerosis. Curr Drug Targets 2010;11:882–887
   PubMed Web of Science ®Google Scholar
• Thivierge M, Doty M, Johnson J, Stankova J, Rola-Pleszczynski M. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 2000;165:5221–5226
   PubMed Web of Science ®Google Scholar
• Thivierge M, Stankova J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 2001;167:2855–2860
   PubMed Web of Science ®Google Scholar
• Watanabe S, Yamasaki A, Hashimoto K, Shigeoka Y, Chikumi H, Hasegawa Y, Sumikawa T, et al. Expression of functional leukotriene B4 receptors on human airway smooth muscle cells. J Allergy Clin Immunol 2009;124:59–65
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Kumik J. Antileukotriene drugs in the treatment of asthma. Polskie Archiwum Medycyny Wewnetrznej 2010;120:103–107
   PubMed Web of Science ®Google Scholar
• Mathis S, Jala V, Lee D, Hari babu B. Nonredundant Roles for Leukotriene B4 Receptors BLT1 and BLT2 in inflammatory arthritis. J Immunol 2010;185:3049–3056
   PubMed Web of Science ®Google Scholar
• Drazen J, Israel E, O’Byrne P. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197–206
   PubMed Web of Science ®Google Scholar
• Haeggstrom J. Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis. J Biol Chem 2004;279:50639–50642
   PubMed Web of Science ®Google Scholar
• Keppler D. Leukotrienes: biosynthesis, transport, inactivation, and analysis. Rev Physiol Biochem Pharmacol 1992;121:1–30
   PubMed Web of Science ®Google Scholar
• Diamant Z, Diderik Boot J, Christian Virchow J. Summing up 100 years of asthma. Respir Med 2007;101:378–388
   PubMed Web of Science ®Google Scholar
• Hay DWP, Torphy TJ, Undem BJ. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 1995;16:304–309
   PubMed Web of Science ®Google Scholar
• Holgate S, Bradding P, Sampson A. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996;98:1–13
   PubMed Web of Science ®Google Scholar
• Ramsay CF, Sullivan P, Gizycki M, Wang D, Swern AS, Barnes NC, Reiss TF, et al. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial. Respir Med 2009;103:995–1003
   PubMed Web of Science ®Google Scholar
• Tintinger G, Feldman C, Theron A, Anderson R. Montelukast: more than a cysteinyl leukotriene receptor antagonist? Scientific World Journal 2010;10:2403–2413
   Web of Science ®Google Scholar
• Blais L, Kettani FZ, Lemiere C, Beauchesne MF, Perreault S, Elftouh N, Ducharme FM. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children. Respir Med 2011;105:846–855
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang J, Bunjhoo H, Xie M, Xu Y, Fang H. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis. Asian Pac J Allergy Immunol 2012;30:130–138
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Miyahara N, Gelfand EW. The role of leukotriene B4 in allergic diseases. Allergol Int 2008;57:291–298
   PubMedGoogle Scholar